NLRP3 and neoplasm: Furthermore, NLRP3 inflammasome may also influence the anti-tumor immune response in LCE patients, as IL-1β can enhance the recruitment and activation of natural killer cells and cytotoxic T cells, which can eliminate tumor cells [22].